LRRK2 and Parkinson disease: Although this axis still needs to be characterized in microglia, Levy and collaborators suggest that the suppression of Epac1/Rap1 by PD-associated LRRK2 could reduce the ability of microglia to migrate to sites of neuronal cell damage in PD [51].